Logo image of ELV

ELEVANCE HEALTH INC (ELV) Stock Analyst Ratings

NYSE:ELV - New York Stock Exchange, Inc. - US0367521038 - Common Stock - Currency: USD

385.1  -5.4 (-1.38%)

After market: 385.1 0 (0%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to ELV. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 504.77. This target is 31.07% above the current price.
ELV was analyzed by 28 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about ELV.
In the previous month the buy percentage consensus was at a similar level.
ELV was analyzed by 28 analysts, which is quite many. So the average rating should be quite meaningful.
ELV Historical Analyst RatingsELV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -31 -28 -25 -22 -19 -16 -13 -10 -7 -4 -1 5 10 15 20 25

Price Target & Forecast

Price Low Median Mean High 385.10391.88491.13504.77656.25 - 1.76% 27.53% 31.07% 70.41%
ELV Current Analyst RatingELV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-01-29 Argus Research Reiterate Hold -> Hold
2025-01-28 Wells Fargo Maintains Overweight -> Overweight
2025-01-24 Cantor Fitzgerald Reiterate Overweight -> Overweight
2025-01-24 Barclays Maintains Overweight -> Overweight
2025-01-06 Truist Securities Maintains Buy -> Buy
2024-11-05 Mizuho Maintains Outperform -> Outperform
2024-11-04 Wells Fargo Maintains Overweight -> Overweight
2024-10-23 Morgan Stanley Maintains Overweight -> Overweight
2024-10-22 Barclays Maintains Overweight -> Overweight
2024-10-21 TD Cowen Maintains Buy -> Buy
2024-10-18 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-10-18 Argus Research Downgrade Buy -> Hold
2024-10-18 UBS Maintains Buy -> Buy
2024-10-18 RBC Capital Maintains Outperform -> Outperform
2024-10-18 Truist Securities Reiterate Buy -> Buy
2024-10-10 Barclays Maintains Overweight -> Overweight
2024-10-01 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-10 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-05 Stephens & Co. Reiterate Overweight -> Overweight
2024-08-19 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-07-23 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-07-22 Wells Fargo Maintains Overweight -> Overweight
2024-07-19 TD Cowen Maintains Buy -> Buy
2024-07-18 RBC Capital Maintains Outperform -> Outperform
2024-07-18 Barclays Maintains Overweight -> Overweight
2024-07-18 B of A Securities Downgrade Buy -> Neutral
2024-07-15 Truist Securities Maintains Buy -> Buy
2024-07-10 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-06-24 Morgan Stanley Initiate Overweight